Yonas Ghebrekristos

Division of Molecular Biology and Human Genetics, Stellenbosch University

Affiliated withStellenbosch University Green Point Tuberculosis Laboratory

Research Area

Biography

Yonas Ghebrekristos has not added Biography.
If you are Yonas Ghebrekristos and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis. The Journal of molecular diagnostics : JMD\| PubMed ID: 35108607	2022
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation. The Lancet. Microbe\| PubMed ID: 37739001	2023
Misdiagnosis of non-tuberculous mycobacteria as tuberculous by the GeneXpert MTB/RIF Ultra: Fact or fiction? Southern African journal of infectious diseases\| PubMed ID: 38628427	2024
Isolation of pure non-tuberculous mycobacteria culture from a mixed growth with conventional microbiology: Techniques not to be forgotten. The Indian journal of tuberculosis\| PubMed ID: 39111929	2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility. Research square\| PubMed ID: 39149464	2024
Identification of nontuberculous mycobacteria using the GenoType CMdirect and GenoType Mycobacterium CM line probe assays in GeneXpert MTB/RIF Ultra negative sputum: A South African prevalen... Diagnostic microbiology and infectious disease\| PubMed ID: 39293319	2024
Targeted deep sequencing of mycobacteria species from extrapulmonary sites not identified by routine line probe assays: A retrospective laboratory analysis of stored clinical cultures. IJID regions\| PubMed ID: 39483154	2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 39663850	2024
Mixed nontuberculous mycobacteria in an immunocompromised patient with probable progressive multifocal leukoencephalopathy. IJID regions\| PubMed ID: 39810748	2025
Non-tuberculosis mycobacteria identified by line probe assays in respiratory and non-respiratory samples in South Africa between 2015 and 2019. Tuberculosis (Edinburgh, Scotland)\| PubMed ID: 39883999	2025
Xpert MTB/RIF Ultra-resistant and MTBDRsusceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. Antimicrobial agents and chemotherapy\| PubMed ID: 39918315	2025
Waste to Worth: A diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis. Research square\| PubMed ID: 40297690	2025
DNA extraction: Implications for NTM identification and amplicon sequencing. Southern African journal of infectious diseases\| PubMed ID: 40469625	2025